Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2021 Jan:221:83-90.
doi: 10.1016/j.ajo.2020.08.014. Epub 2020 Aug 18.

Instrument Gauge and Type in Uveal Melanoma Fine Needle Biopsy: Implications for Diagnostic Yield and Molecular Prognostication

Affiliations
Comparative Study

Instrument Gauge and Type in Uveal Melanoma Fine Needle Biopsy: Implications for Diagnostic Yield and Molecular Prognostication

Lindsay K Klofas et al. Am J Ophthalmol. 2021 Jan.

Abstract

Purpose: To systematically evaluate and compare the effects of using small-gauge needles and vitrectors on the ability to obtain adequate diagnostic and prognostic uveal melanoma biopsy specimens.

Design: Comparative evaluation of biopsy instruments.

Methods: Survival of uveal melanoma cells was evaluated in vitro following needle aspiration. Five therapeutically enucleated eyes were sampled in triplicate for ex vivo diagnostic biopsy experiments with 25 gauge (25 G) needle, 27 gauge (27 G) needle, and 27 G vitrector. During surgery in 8 patients, paired diagnostic transscleral fine needle aspiration biopsies were performed using both 25 G and 27 G needles. A review of cytologic specimens was performed by a panel of 3 expert cytopathologists. A retrospective chart review was performed to evaluate 100 consecutive tumors undergoing prognostic biopsy for gene expression profiling to assess the relationship between needle gauge and prognostic adequacy.

Results: No significant cell shearing of uveal melanoma cells occurred in vitro with 25 G, 27 G, or 30 G needles. For ex vivo biopsy samples, diagnostic yield was 100% using 25 G needle (5/5) or 27 G vitrector (5/5) but 60% using a 27 G needle (3/5). For in vivo samples, no difference in diagnostic yield was found between 25 G (75%, 6/8) or 27 G (75%, 6/8) needle sizes. Of 100 molecular prognostic biopsy samples evaluated, 65 were obtained using 27 G needles; for these biopsies, the prognostic yield was 65/65 (100%).

Conclusions: For diagnostic biopsy of uveal melanoma, a larger-gauge needle or a 27 G vitrector may have better overall cellularity and diagnostic yield when compared to a 27 G needle. However, for much more common molecular prognostic testing, a 27 G needle provided adequate sample in 100% (65/65) of cases, and a larger needle provided no additional benefit.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Cell survival of uveal melanoma cell lines following aspiration and expulsion from various small-gauge needle sizes to simulate fine needle aspiration biopsy. Smaller-gauge needles did not decrease cell viability of any of the 3 cell lines tested: Mel270 (spindle cell morphology), OM431 (epithelioid cell morphology), or OCM1 (mixed spindle and epithelioid cell morphology). Experiments were performed as 5 replicates per cell line, and viability within each cell line following passage through each needle gauge was compared to the unaspirated control and to other needle gauges using 1-way analysis of variance (ANOVA) with Tukey’s multiple comparisons. Each is expressed as a percent of the unaspirated controls, and error bars represent standard deviations. Significance was set at P < .05 and no decreases in viability were found. Mel270: 1-way ANOVA, P = .0865; Tukey’s multiple comparisons: 25 G vs 27 G, P = .9681; 25 G vs 30 G, P = .2462; 27 G vs 30 G, P = .116. OCM1: 1-way ANOVA, P = .9262; Tukey’s multiple comparisons: 25 G vs 27 G, P = .9994; 25 G vs 30 G, P = .9845; 27 G vs 30 G, P = .9953. OM431: 1-way ANOVA, P = .6982; Tukey’s multiple comparisons: 25 G vs 27 G, P = .9832; 25 G vs 30 G, P = .9997; 27 G vs 30 G, P = .9677.
FIGURE 2.
FIGURE 2.
Cytopathologic evaluation of ocular melanoma aspirates. (A) Diff-Quik preparation of ex vivo fine needle aspirates performed using a 27 gauge needle, 25 gauge needle, and 27 gauge vitrector. For each gauge, 3 separate aspiration samplings were performed from different locations within each tumor (using separate needles/set-ups). (B) Hematoxylin-eosin preparation of in vivo fine needle aspirates performed using 27 gauge and 25 gauge needles. (C) Cell block preparation following 27 gauge vitrector aspiration. All images obtained at 20× magnification, scale bar 50 μm.

Similar articles

Cited by

References

    1. Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS report no. 1. Arch Ophthalmol 1990;108(9):1268–1273. - PubMed
    1. Char DH, Miller T. Accuracy of presumed uveal melanoma diagnosis before alternative therapy. Br J Ophthalmol 1995; 79(7):692–696. - PMC - PubMed
    1. Jensen OA, Prause JU, Scherfig E. Transvitreal retinochoroidal biopsy of suspected malignant lesions of the choroid. Follow-up of cases over 7 years. Acta Ophthalmol Scand 1997;75(4):409–411. - PubMed
    1. Cerbone L, Van Ginderdeuren R, Van den Oord J, et al. Clinical presentation, pathological features and natural course of metastatic uveal melanoma, an orphan and commonly fatal disease. Oncology 2014;86(3):185–189. - PubMed
    1. Kujala E, Makitie T, Kivela T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 2003;44(11):4651–4659. - PubMed

Publication types

MeSH terms

Substances